Reduced vs. standard dose native E. coli-asparaginase therapy in childhood acute lymphoblastic leukemia: long-term results of the randomized trial Moscow–Berlin 2002

PURPOSE: Favorable outcomes were achieved for children with acute lymphoblastic leukemia (ALL) with the first Russian multicenter trial Moscow–Berlin (ALL-MB) 91. One major component of this regimen included a total of 18 doses of weekly intramuscular (IM) native Escherichia coli-derived asparaginas...

Descripción completa

Detalles Bibliográficos
Autores principales: Karachunskiy, Alexander, Tallen, Gesche, Roumiantseva, Julia, Lagoiko, Svetlana, Chervova, Almira, von Stackelberg, Arend, Aleinikova, Olga, Bydanov, Oleg, Bajdun, Lyudmila, Nasedkina, Tatiana, Korepanova, Natalia, Kuznetsov, Sergei, Novichkova, Galina, Goroshkova, Marina, Litvinov, Dmitry, Myakova, Natalia, Ponomareva, Natalia, Inyushkina, Evgeniya, Kondratchik, Konstantin, Abugova, Julia, Fechina, Larisa, Arakaev, Oleg, Karelin, Alexander, Lebedev, Vladimir, Judina, Natalia, Scharapova, Gusel, Spichak, Irina, Shamardina, Anastasia, Ryskal, Olga, Shapochnik, Alexander, Rumjanzew, Alexander, Boos, Joachim, Henze, Günter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2019
Materias:
Original Article – Clinical Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6435612/
https://www.ncbi.nlm.nih.gov/pubmed/30840197
http://dx.doi.org/10.1007/s00432-019-02854-x

Ejemplares similares

Ejemplares similares